Results 61 to 70 of about 5,251,416 (217)

Modulation of the CD8+-T-cell response by CD4+ CD25+ regulatory T cells in patients with Hepatitis B virus infection

open access: yes, 2005
CD4+ CD25+ regulatory T cells have been shown to maintain peripheral tolerance against self and foreign antigens. In this study we analyzed the effect of circulating CD4+ CD25+ T cells on CD8+-T-cell responses of patients with chronic and resolved ...
Gotto, J   +19 more
core   +1 more source

Functional characteristics of the gene promoters of anti-inflammatory cytokines TGF-b and IL-10 in B lymphocyte cell models

open access: yesМедицинская иммунология
B cells play a crucial role in the pathogenesis of various diseases, such as autoimmune disorders, cancers, and infections. Unlike regulatory T cells, the anti-inflammatory capabilities of B cells have only recently garnered attention.
A. N. Uvarova   +5 more
doaj   +1 more source

Human hematopoietic stem/progenitor cells generate CD5+ B lymphoid cells in NOD/SCID mice

open access: yes, 1999
The nonobese diabetic/severe combined immunodeficient (NOD/SCID) xenotransplantation model is increasingly utilized to study both human lymphohematopoietic stem/progenitor cells and committed cell types.
Ramírez, Manuel   +3 more
core   +1 more source

The transcription factors Egr2 and Egr3 are essential for the control of inflammation and antigen-induced proliferation of B and T cells [PDF]

open access: yes, 2012
This article is available open access under a Creative Commons license (http://creativecommons.org/licenses/by-nc-nd/3.0/). Copyright @ 2012 Elsevier Inc.Lymphocytes provide optimal responses against pathogens with minimal inflammatory pathology. However,
Miao, T   +15 more
core   +1 more source

B cells in transplantation [PDF]

open access: yesThe Journal of Heart and Lung Transplantation, 2016
B cell responses underlie the most vexing immunological barriers to organ transplantation. Much has been learned about the molecular mechanisms of B cell responses to antigen and new therapeutic agents that specifically target B cells or suppress their functions are available.
Esme I, Dijke   +6 more
openaire   +2 more sources

Clinical Features and Prognosis of 74 Cases of Lymphoblastic Lymphoma

open access: yesZhongliu Fangzhi Yanjiu, 2018
Objective To analyze clinical features of lymphoblastic lymphoma(LBL), compare clinical and prognostic characteristics of B lymphoblasts lymphoma (B-LBL) and T lymphoblasts lymphoma (T-LBL), and the prognosis of various chemotherapy regimens on LBL ...
YUAN Ying   +4 more
doaj   +1 more source

Immunotherapeutic targeting of membrane Hsp70-expressing tumors using recombinant human granzyme B [PDF]

open access: yes, 2012
Background: We have previously reported that human recombinant granzyme B (grB) mediates apoptosis in membrane heat shock protein 70 (Hsp70)-positive tumor cells in a perforin-independent ...
Axel Walch   +39 more
core   +1 more source

Atypical Mitochondrial Phenotype of Colonic CD4+ and CD8+ T Cells During Experimental Chronic Colitis

open access: yesBiomedicines
Background: Patients with ulcerative colitis (UC) suffer from a chronic relapsing-remitting inflammatory bowel disease and show heterogeneous disease severity and therapy response.
Jonas Negele   +10 more
doaj   +1 more source

B cells and the humoral response in melanoma: The overlooked players of the tumor microenvironment

open access: yesOncoImmunology, 2017
Evidence of tumor-resident mature B cell and antibody compartments and reports of associations with favorable prognosis in malignant melanoma suggest that humoral immunity could participate in antitumor defense.
Giulia Chiaruttini   +6 more
doaj   +1 more source

RelB is differentially regulated by IkappaB Kinase-alpha in B cells and mouse lung by cigarette smoke [PDF]

open access: yes, 2009
The activation of transcription factor NF-kappaB is controlled by two main pathways: the classical canonical (RelA/p65-p50)- and the alternative noncanonical (RelB/p52)-NF-kappaB pathways.
Edirisinghe, Indika   +12 more
core   +1 more source

Home - About - Disclaimer - Privacy